Aethlon Medical Inc. (AEMD)
Aethlon Medical Statistics
Share Statistics
Aethlon Medical has 16.09M shares outstanding. The number of shares has increased by 48.62% in one year.
| Shares Outstanding | 16.09M |
| Shares Change (YoY) | 48.62% |
| Shares Change (QoQ) | 47.95% |
| Owned by Institutions (%) | 3.16% |
| Shares Floating | 15.11M |
| Failed to Deliver (FTD) Shares | 4.42K |
| FTD / Avg. Volume | 1.93% |
Short Selling Information
The latest short interest is 56.13K, so 0.35% of the outstanding shares have been sold short.
| Short Interest | 56.13K |
| Short % of Shares Out | 0.35% |
| Short % of Float | 0.35% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.36 and the forward PE ratio is -0.71. Aethlon Medical's PEG ratio is 0.02.
| PE Ratio | -0.36 |
| Forward PE | -0.71 |
| PS Ratio | 0 |
| Forward PS | 0 |
| PB Ratio | 0.75 |
| P/FCF Ratio | -0.42 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aethlon Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.4, with a Debt / Equity ratio of 0.16.
| Current Ratio | 3.4 |
| Quick Ratio | 3.4 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | -0.08 |
| Debt / FCF | -0.09 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-872.01K |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 3 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -72.26% in the last 52 weeks. The beta is 1.72, so Aethlon Medical's price volatility has been higher than the market average.
| Beta | 1.72 |
| 52-Week Price Change | -72.26% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 0.46 |
| Relative Strength Index (RSI) | 48.32 |
| Average Volume (20 Days) | 229.02K |
Income Statement
| Revenue | n/a |
| Gross Profit | -359.06K |
| Operating Income | -12.64M |
| Net Income | -12.21M |
| EBITDA | -11.85M |
| EBIT | -12.21M |
| Earnings Per Share (EPS) | -4.86 |
Balance Sheet
The company has 5.44M in cash and 940.32K in debt, giving a net cash position of 4.5M.
| Cash & Cash Equivalents | 5.44M |
| Total Debt | 940.32K |
| Net Cash | 4.5M |
| Retained Earnings | -154.57M |
| Total Assets | 6.53B |
| Working Capital | 3.19B |
Cash Flow
In the last 12 months, operating cash flow was -10.13M and capital expenditures -250.87K, giving a free cash flow of -10.38M.
| Operating Cash Flow | -10.13M |
| Capital Expenditures | -250.87K |
| Free Cash Flow | -10.38M |
| FCF Per Share | -4.13 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AEMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for AEMD is $7, which is 1742.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 1742.1% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Oct 5, 2023. It was a backward split with a ratio of 1:10.
| Last Split Date | Oct 5, 2023 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -34.11 |
| Piotroski F-Score | 0 |